CLINICAL PHENOTYPES OF DIFFERENT MPZ (P-0) MUTATIONS MAY INCLUDE CHARCOT-MARIE-TOOTH TYPE 1B, DEJERINE-SOTTAS, AND CONGENITAL HYPOMYELINATION

Citation
Le. Warner et al., CLINICAL PHENOTYPES OF DIFFERENT MPZ (P-0) MUTATIONS MAY INCLUDE CHARCOT-MARIE-TOOTH TYPE 1B, DEJERINE-SOTTAS, AND CONGENITAL HYPOMYELINATION, Neuron, 17(3), 1996, pp. 451-460
Citations number
53
Categorie Soggetti
Neurosciences
Journal title
NeuronACNP
ISSN journal
08966273
Volume
17
Issue
3
Year of publication
1996
Pages
451 - 460
Database
ISI
SICI code
0896-6273(1996)17:3<451:CPODM(>2.0.ZU;2-9
Abstract
Hereditary demyelinating peripheral neuropathies consist of a heteroge neous group of genetic disorders that includes hereditary neuropathy w ith liability to pressure palsies (HNPP), Charcot-Marie-Tooth disease (CMT), Dejerine-Sottas syndrome (DSS), and congenital hypomyelination (CH). The clinical classification of these neuropathies into discrete categories can sometimes be difficult because there can be both clinic al and pathologic variation and overlap between these disorders. We ha ve identified five novel mutations in the myelin protein zero (MPZ) ge ne, encoding the major structural protein (P-0) of peripheral nerve my elin, in patients with either CMT1B, DSS, or CH. This finding suggests that these disorders may not be distinct pathophysiologic entities, b ut rather represent a spectrum of related ''myelinopathies'' due to an underlying defect in myelination. Furthermore, we hypothesize the dif ferences in clinical severity seen with mutations in MPZ are related t o the type of mutation and its subsequent effect on protein function ( i.e., loss of function versus dominant negative).